Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Curiel

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Frontiers in Aging Neuroscience|February 15, 2024
Different aspects of failing to recover from proactive semantic interference predicts rate of progression from amnestic mild cognitive impairment to dementiaRosie E Curiel Cid, Elizabeth A Crocco, Ranjan Duara, et al.
Journal of Alzheimer'S Disease : JAD|June 2, 2026
Combining plasma biomarkers and cognitive challenge tests enhances prediction of functional trajectories of decline among older adults with cognitive impairmentD Diane Zheng, Rosie E Curiel Cid, Alexandra Ortega, et al.
Cancer|November 1, 2005
Phase II study of pemetrexed in combination with carboplatin in the first-line treatment of advanced nonsmall cell lung cancerRalph G Zinner, Frank V Fossella, Gregory W Gladish, et al.
Frontiers in Neurology|August 6, 2025
Semantic intrusion errors differentiate between amnestic MCI who are plasma p-tau<sub>217</sub>+ from p-tau<sub>217</sub>- after adjusting for initial learning strengthRosie E Curiel Cid, David Vaillancourt, Alexandra Ortega, et al.
Biomolecules|May 27, 2026
Common Medical Comorbidities, Demographic Factors and Levels of Plasma Biomarkers of Alzheimer's Disease and Neurodegeneration in Black/African American Older AdultsRosie E Curiel Cid, Alexandra Ortega, Kirsten Crenshaw, et al.
Ageing Research Reviews|September 21, 2024
Neuroimaging and biofluid biomarkers across race and ethnicity in older adults across the spectrum of cognitionWei-En Wang, Breton M Asken, Jesse C DeSimone, et al.
Advances in Alzheimer'S Disease|April 20, 2026
Detecting Cognitive Impairment in African American Older Adults Using the LASSI-L and Plasma P-Tau<sub>217</sub>Kirsten Horne Crenshaw, Alexandra Ortega, Rosie E Curiel Cid, et al.
The Journal of Prevention of Alzheimer'S Disease|January 12, 2025
Informing etiological heterogeneity of mild cognitive impairment and risk for progression to dementia with plasma p-tau217Breton M Asken, Rosie E Curiel Cid, Elizabeth A Crocco, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 19, 2026
Factors associated with discordant visual and quantitative amyloid PET resultsJasmin E Guevara, Emily F Matusz, Wei-En Wang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 5, 2025
Moderating effects of plasma glial fibrillary acidic protein along the Alzheimer's disease continuumShannon Y Lee, Valentina E Diaz, Olivia M Emanuel, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Frontiers in Aging Neuroscience|February 15, 2024
Different aspects of failing to recover from proactive semantic interference predicts rate of progression from amnestic mild cognitive impairment to dementiaRosie E Curiel Cid, Elizabeth A Crocco, Ranjan Duara, et al.
Journal of Alzheimer'S Disease : JAD|June 2, 2026
Combining plasma biomarkers and cognitive challenge tests enhances prediction of functional trajectories of decline among older adults with cognitive impairmentD Diane Zheng, Rosie E Curiel Cid, Alexandra Ortega, et al.
Cancer|November 1, 2005
Phase II study of pemetrexed in combination with carboplatin in the first-line treatment of advanced nonsmall cell lung cancerRalph G Zinner, Frank V Fossella, Gregory W Gladish, et al.
Frontiers in Neurology|August 6, 2025
Semantic intrusion errors differentiate between amnestic MCI who are plasma p-tau<sub>217</sub>+ from p-tau<sub>217</sub>- after adjusting for initial learning strengthRosie E Curiel Cid, David Vaillancourt, Alexandra Ortega, et al.
Biomolecules|May 27, 2026
Common Medical Comorbidities, Demographic Factors and Levels of Plasma Biomarkers of Alzheimer's Disease and Neurodegeneration in Black/African American Older AdultsRosie E Curiel Cid, Alexandra Ortega, Kirsten Crenshaw, et al.
Ageing Research Reviews|September 21, 2024
Neuroimaging and biofluid biomarkers across race and ethnicity in older adults across the spectrum of cognitionWei-En Wang, Breton M Asken, Jesse C DeSimone, et al.
Advances in Alzheimer'S Disease|April 20, 2026
Detecting Cognitive Impairment in African American Older Adults Using the LASSI-L and Plasma P-Tau<sub>217</sub>Kirsten Horne Crenshaw, Alexandra Ortega, Rosie E Curiel Cid, et al.
The Journal of Prevention of Alzheimer'S Disease|January 12, 2025
Informing etiological heterogeneity of mild cognitive impairment and risk for progression to dementia with plasma p-tau217Breton M Asken, Rosie E Curiel Cid, Elizabeth A Crocco, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 19, 2026
Factors associated with discordant visual and quantitative amyloid PET resultsJasmin E Guevara, Emily F Matusz, Wei-En Wang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 5, 2025
Moderating effects of plasma glial fibrillary acidic protein along the Alzheimer's disease continuumShannon Y Lee, Valentina E Diaz, Olivia M Emanuel, et al.
Pageof 12